Gene therapy applications for fracture-healing

Journal of Bone and Joint Surgery

Volumn 90, Issue SUPPL. 1, 2008, Pages 99-110

  Carofino, Bradley C ^b   Lieberman, Jay R ^a  

^a Medical Arts and Research Building   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 9; CALCIUM PHOSPHATE; COLLAGEN SPONGE; COLLAGEN TYPE 1; COMPLEMENTARY DNA; DNA; FIBROBLAST GROWTH FACTOR; HYALURONIC ACID; HYDROXYAPATITE; LIPOSOME; MATRIX PROTEIN; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN; POLYLACTIDE; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; SCAFFOLD PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR OSTERIX; UNINDEXED DRUG; VASCULOTROPIN; VIRUS VECTOR;

CONFERENCE PAPER; DRUG RESEARCH; FRACTURE; FRACTURE HEALING; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; TREATMENT INDICATION; VIRAL GENE DELIVERY SYSTEM;

EID: 40149095754     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.G.01546     Document Type: Conference Paper

References (98)